# INTERVIEW: Sativa Investments UK interest in medicinal cannabis is building

- Link: https://www.directorstalkinterviews.com/interview-sativa-investments-uk-interest-medicinal-cannabis-building/412753380
- Published: 2018-06-26T07:51:12+01:00
- Author: Giles Arbor

**Sativa Investments Plc** ([NEX:SATI](https://www.directorstalkinterviews.com/company/goodbody-health/gdby.cn))
CEO Geremy Thomas talks to DirectorsTalk about the Appointment of Sir Breckenridge
to the advisory board, share price movement, resolutions at GM, what George Botanicals
brings to the portfolio and now with the UK interest in medicinal cannabis is building
how the Sativa Foundation play a role in Sativa’s own growth.

Sativa Investments will look for well-placed opportunities within the dynamic regulatory
environment of the Medicinal Cannabis sector and the Company’s investment strategy
will focus on the production, testing and compliance, research and development, 
including pharmacology, commercialisation and sales and marketing of Medicinal Cannabis
in jurisdictions where it is regulatorily accepted, with an initial focus on Canada.
The Company has committed to an independent legal review prior to each investment
to verify compliance with the prevailing regulatory environment.

The Company’s equity interest in a proposed investment may range from a minority
position, to a controlling interest, or to 100 per cent ownership. The ventures 
that Sativa intends to acquire can either be public or private.

The Company’s Board and Medical Cannabis Advisory Board have a combined 60 years’
industry experience with strong and extensive contacts in the industry, with significant
pharmaceutical strength and experience. Their extensive skills range from capital
fund raisings, medical research, and start-ups, to pharmaceutical development.

Share on: